Anti-Neurofibromin antibody [EPR22989-68]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(2 Publications)
Rabbit Recombinant Monoclonal Neurofibromin antibody. Suitable for WB and reacts with Mouse, Rat, Human samples. Cited in 2 publications.
View Alternative Names
Neurofibromin, Neurofibromatosis-related protein NF-1, NF1
- WB
Lab
Western blot - Anti-Neurofibromin antibody [EPR22989-68] (AB238142)
Lanes 1-3 : Merged signal (red and green). Green - ab238142 observed at 319 kDa. Red - loading control ab7291 observed at 50 kDa.
ab238142 Recombinant Anti-NF1 antibody [EPR22989-68] was shown to specifically react with NFIB in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab264725 (knockout cell lysate ab258533) was used. Wild-type and NF1 knockout samples were subjected to SDS-PAGE. ab238142 and Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Neurofibromin antibody [EPR22989-68] (ab238142) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
NFIB knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human NF1 (Neurofibromin) knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-nf1-neurofibromin-knockout-hela-cell-line-ab264725'>ab264725</a>)
Lane 3:
HAP1 cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/20000 dilution
Predicted band size: 319 kDa
Observed band size: 319 kDa
false
- WB
Lab
Western blot - Anti-Neurofibromin antibody [EPR22989-68] (AB238142)
Anti-NF1 antibody [EPR22989-68] (ab238142) staining at 1/1000 dilution, shown in green; Mouse anti-CANX [CANX/1543] (ab238078) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab238142 was shown to bind specifically to NF1. A band was observed at 180-270 kDa in wild-type MCF7 cell lysates with no signal observed at this size in NF1 knockout cell line. To generate this image, wild-type and NF1 knockout MCF7 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-Neurofibromin antibody [EPR22989-68] (ab238142) at 1/1000 dilution
Lanes 1 - 4:
Western blot at 20 µg
Lane 2:
Western blot - Human NF1 knockout MCF7 cell line (<a href='/en-us/products/cell-lines/human-nf1-knockout-mcf7-cell-line-ab286416'>ab286416</a>) at 20 µg
Secondary
All lanes:
Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Predicted band size: 319 kDa
false
- WB
Lab
Western blot - Anti-Neurofibromin antibody [EPR22989-68] (AB238142)
ab238142 was shown to specifically react with Neurofibromin in wild-type HAP1 cells as signal was lost in Neurofibromin knockout cells. Wild-type and Neurofibromin knockout samples were subjected to SDS-PAGE. ab238142 and ab129002 (Rabbit anti-Vinculin loading control) were incubated 1 hour at room temperature at 1/1000 dilution and 1/5000 dilution respectively. Blots were developed with Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) secondary antibody at 1/100,000 dilution for 1 hour at room temperature before imaging. The blot was developed on a BIO-RAD® ChemiDoc™ MP instrument using the ECL technique. Lysate should be made freshly and used in WB immediately to minimize protein degradation. Degraded fragment(250 KD) observed is consistent with what has been described in the literature (PMID : 30131853, PMID : 30408279).
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Exposure time : 26 seconds
All lanes:
Western blot - Anti-Neurofibromin antibody [EPR22989-68] (ab238142) at 1/1000 dilution
Lane 1:
Wild-type HAP1 whole cell lysate at 20 µg
Lane 2:
Neurofibromin knockout HAP1 whole cell lysate at 20 µg
Lane 3:
HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 319 kDa
Observed band size: 250 kDa,300 kDa
false
- WB
Lab
Western blot - Anti-Neurofibromin antibody [EPR22989-68] (AB238142)
Degraded fragments (200-250 KD) observed is consistent with what has been described in the literature (PMID : 30131853, PMID : 30408279).
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Exposure time : Lane 1 : 3 minutes; Lane 2 : 26 seconds; Lanes 3-5 : 3 minutes.
All lanes:
Western blot - Anti-Neurofibromin antibody [EPR22989-68] (ab238142) at 1/1000 dilution
Lane 1:
Mouse brain lysate at 20 µg
Lane 2:
Rat brain lysate at 20 µg
Lane 3:
NIH/3T3 (mouse embryonic fibroblast) whole cell lysate at 20 µg
Lane 4:
MEF (mouse embryonic fibroblast (immortalized)) whole cell lysate at 20 µg
Lane 5:
PC-12 (rat adrenal gland heochromocytoma) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 319 kDa
Observed band size: 200 kDa,250 kDa,300 kDa
false
Related conjugates and formulations (1)
-
Anti-Neurofibromin antibody [EPR22989-68] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Neurofibromin regulates pathways involved in cell growth and development. It does not form part of a large multiprotein complex but interacts with microtubules and other signaling proteins to carry out its regulatory functions. Neurofibromin primarily affects pathways that manage cell cycle progression and it plays a critical role in inhibiting uncontrolled cell growth ensuring proper cellular homeostasis.
Pathways
Neurofibromin fits into the Ras-MAPK pathway where it controls the activity of Ras an important regulatory protein involved in signal transduction related to cell division and differentiation. Neurofibromin's action on Ras directly impacts the activation of the MAPK pathway which is important in mediating cellular responses to growth signals. This protein also interacts functionally with proteins like SOS1 another regulator of Ras emphasizing its role in fine-tuning signal cascades that ensure balanced cellular function.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
The Journal of clinical investigation 135: PubMed40590220
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular oncology 19:825-851 PubMed39129390
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com